{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:27:42Z","timestamp":1793672862386,"version":"4.5.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Union","award":["PE00000015"],"award-info":[{"award-number":["PE00000015"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union","award":["PNRR-MCNT2-2023-12377968"],"award-info":[{"award-number":["PNRR-MCNT2-2023-12377968"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Up to 45% of dementia can be prevented by addressing modifiable risk factors. Brain Health Services (BHS) are emerging across Europe, targeting individuals with subjective cognitive decline (SCD) to assess, communicate and reduce their risk of dementia. Our aim is to characterize our BHS cohort, and assess differences in clinical, biological, neuroimaging, and impact of biomarker disclosure based on plasma Lumipulse p-Tau217.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed baseline data from 186 consecutive individuals seen at our BHS (132 SCD). Cumulative dementia risk was calculated using the total Lancet relative risk (RR). Participants were grouped in plasma Lumipulse p-Tau217 above and below 0.15 pg\/mL (A\u2009+\u2009and A\u2013). Cluster analysis was performed with k-means.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The most prevalent potentially modifiable factors among participants with SCD were sleep impairment, smoking, physical inactivity, and hypertension. A\u2009+\u2009SCD subjects (32%) were older and showed worse performance on cognitive screening tests (\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>FDR<\/jats:italic>\n                      <\/jats:sub>\n                      &lt; 0.05). A\u2009+\u2009SCD showed higher GFAP and neurodegeneration on visual scales (\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>FDR<\/jats:italic>\n                      <\/jats:sub>\n                      &lt; 0.05). Two clusters were identified, one with low modifiable and biological risk and high cognition, and another with high risk and lower cognition. Disclosure was well accepted, with no differences between A\u2013 and A\u2009+\u2009in depression and anxiety.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our findings showed a high prevalence of modifiable risk factors in SCD. A+ individuals demonstrated biological and structural hallmarks of early neurodegeneration. Biomarker disclosure was feasible, reflecting the potential benefits of transparent risk communication. These findings support incorporating plasma biomarkers and structured disclosure protocols in BHS, complementing multimodal prevention strategies to delay dementia onset.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10072-026-09426-1","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:54:07Z","timestamp":1790661247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dementia risk factors and biomarkers in subjective cognitive decline: real world evidence from the monza brain health service"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2982-9165","authenticated-orcid":false,"given":"Federico Emanuele","family":"Pozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Solivani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Vitagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Isgr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Remoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Gabriela","family":"Macias Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cuffaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gessica","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Andreoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Paola","family":"Zoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Cerina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Tremolizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildebrando","family":"Appollonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"9426_CR1","doi-asserted-by":"crossref","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S et al (2024) Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet [Internet]. [cited 2026 Jan 3];404(10452):572\u2013628. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0140673624012960","DOI":"10.1016\/S0140-6736(24)01296-0"},{"key":"9426_CR2","doi-asserted-by":"crossref","unstructured":"Jessen F, Amariglio RE, Van Boxtel M, Breteler M, Ceccaldi M, Ch\u00e9telat G et al (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement [Internet]. Nov 1 [cited 2026 Jan 4];10(6):844\u201352. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24798886\/","DOI":"10.1016\/j.jalz.2014.01.001"},{"key":"9426_CR3","doi-asserted-by":"crossref","unstructured":"Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL et al (2020) The characterisation of subjective cognitive decline. Lancet Neurol [Internet]. [cited 2026 Jan 4];19(3):271\u20138. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1474442219303680","DOI":"10.1016\/S1474-4422(19)30368-0"},{"key":"9426_CR4","doi-asserted-by":"crossref","unstructured":"Jack CR, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement [Internet]. [cited 2026 Jan 3];20(8):5143\u201369. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38934362\/","DOI":"10.1002\/alz.13859"},{"key":"9426_CR5","doi-asserted-by":"crossref","unstructured":"Dubois B, Villain N, Schneider L, Fox N, Campbell N, Galasko D et al (2024) Alzheimer disease is a clinical-biological construct: An IWG recommendation. JAMA Neurol [Internet]. Dec 9 [cited 2026 Jul 15];81(12):1304. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12010406\/","DOI":"10.1001\/jamaneurol.2024.3770"},{"key":"9426_CR6","doi-asserted-by":"crossref","unstructured":"Ketchum FB, Erickson CM, Basche KE, Chin NA, Eveler ML, Conway CE et al (2024) Informing alzheimer\u2019s biomarker communication: Concerns and understanding of cognitively unimpaired adults during amyloid results disclosure. J Prevention Alzheimer\u2019s Disease [Internet]. [cited 2026 Jul 15];11(6):1572\u201380. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39559870\/","DOI":"10.14283\/jpad.2024.151"},{"key":"9426_CR7","doi-asserted-by":"publisher","unstructured":"Gustavsson A, Norton N, Fast T, Fr\u00f6lich L, Georges J, Holzapfel D et al (2023) Global estimates on the number of persons across the Alzheimer\u2019s disease continuum. Alzheimer\u2019s & Dementia [Internet]. [cited 2026 Jan 4];19(2):658\u201370. Available from: https:\/\/doi.org\/10.1002\/alz.12694","DOI":"10.1002\/alz.12694"},{"key":"9426_CR8","doi-asserted-by":"crossref","unstructured":"Frisoni GB, Ribaldi F, Allali G, Bieth T, Brioschi Guevara A, Cappa S et al (2025) Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities. J Prev Alzheimers Dis [Internet]. [cited 2026 Jan 3];12(5):100098. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2274580725000421","DOI":"10.1016\/j.tjpad.2025.100098"},{"key":"9426_CR9","doi-asserted-by":"crossref","unstructured":"Rami L, Mollica MA, Garcfa-Sanchez C, Saldafia J, Sanchez B, Sala I et al (2014) The Subjective Cognitive Decline Questionnaire (SCD-Q): a validation study. J Alzheimers Dis [Internet]. [cited 2026 Jan 4];41(2):453\u201366. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24625794\/","DOI":"10.3233\/JAD-132027"},{"key":"9426_CR10","doi-asserted-by":"crossref","unstructured":"van Harten AC, Mielke MM, Swenson-Dravis DM, Hagen CE, Edwards KK, Roberts RO et al (2018) Subjective cognitive decline and risk of MCI: The Mayo Clinic Study of Aging. Neurology [Internet]. [cited 2026 Jan 4];91(4):e300\u201312. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29959257\/","DOI":"10.1212\/WNL.0000000000005863"},{"key":"9426_CR11","doi-asserted-by":"crossref","unstructured":"Sofi F, Dinu M, Pagliai G, Marcucci R, Casini A (2017) Validation of a literature-based adherence score to Mediterranean diet: the MEDI-LITE score. Int J Food Sci Nutr [Internet]. [cited 2026 Mar 16];68(6):757\u201362. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28276908\/","DOI":"10.1080\/09637486.2017.1287884"},{"key":"9426_CR12","doi-asserted-by":"crossref","unstructured":"Nucci M, Mapelli D, Mondini S (2012) Cognitive Reserve Index questionnaire (CRIq): a new instrument for measuring cognitive reserve. Aging Clin Exp Res [Internet]. [cited 2026 Jan 4];24(3):218\u201326. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21691143\/","DOI":"10.1007\/BF03654795"},{"key":"9426_CR13","doi-asserted-by":"crossref","unstructured":"Pirozzo S, Papinczak T, Glasziou P (2003) Whispered voice test for screening for hearing impairment in adults and children: systematic review. BMJ: British Med J [Internet]. [cited 2026 Mar 16];327(7421):967. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC259166\/","DOI":"10.1136\/bmj.327.7421.967"},{"key":"9426_CR14","doi-asserted-by":"crossref","unstructured":"Contador J, Pozzi FE, S\u00e1nchez-Benavides G, Fern\u00e1ndez-Arcos A, Lantero-Rodr\u00edguez J, Montoliu-Gaya L et al (2026) Detecting amyloid\u2013\u03b2 pathology in subjective cognitive decline using plasma and CSF biomarkers. EBioMedicine [Internet]. Jul 1 [cited 2026 Jul 14];129:106331. Available from: https:\/\/www.thelancet.com\/action\/showFullText?pii=S2352396426002148","DOI":"10.1016\/j.ebiom.2026.106331"},{"key":"9426_CR15","doi-asserted-by":"crossref","unstructured":"Scheltens P, Kuiper M, Ch Wolters E, Barkhof F, Valk J, Weinsten HC et al (1992) Atrophy of medial temporal lobes on MRI in probable Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry [Internet]. [cited 2026 Jan 4];55(10):967\u201372. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/1431963\/","DOI":"10.1136\/jnnp.55.10.967"},{"key":"9426_CR16","doi-asserted-by":"publisher","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s and Dementia [Internet]. 7(3):270\u20139. Available from: https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"9426_CR17","doi-asserted-by":"crossref","unstructured":"Ball HA, McWhirter L, Ballard C, Bhome R, Blackburn DJ, Edwards MJ et al (2020) Functional cognitive disorder: dementia\u2019s blind spot. Brain [Internet]. [cited 2026 Mar 19];143(10):2895\u2013903. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32791521\/","DOI":"10.1093\/brain\/awaa224"},{"key":"9426_CR18","doi-asserted-by":"crossref","unstructured":"McWhirter L, Ritchie C, Stone J, Carson A (2022) Identifying functional cognitive disorder: a proposed diagnostic risk model. CNS Spectr [Internet]. Dec 17 [cited 2026 Mar 19];27(6):754\u201363. Available from: https:\/\/www.cambridge.org\/core\/journals\/cns-spectrums\/article\/abs\/identifying-functional-cognitive-disorder-a-proposed-diagnostic-risk-model\/C5E12DC606AFB33C3AB61C92BB942F88","DOI":"10.1017\/S1092852921000845"},{"key":"9426_CR19","doi-asserted-by":"crossref","unstructured":"Frisoni GB, Molinuevo JL, Altomare D, Carrera E, Barkhof F, Berkhof J et al (2020) Precision prevention of Alzheimer\u2019s and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Alzheimers Dement [Internet]. [cited 2026 Mar 16];16(10):1457\u201368. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32815289\/","DOI":"10.1002\/alz.12132"},{"key":"9426_CR20","doi-asserted-by":"crossref","unstructured":"Frisoni GB, Altomare D, Ribaldi F, Villain N, Brayne C, Mukadam N et al (2023) Dementia prevention in memory clinics: recommendations from the European task force for brain health services. The Lancet Regional Health - Europe [Internet]. [cited 2026 Jan 4];26:100576. Available from: https:\/\/www.thelancet.com\/action\/showFullText?pii=S2666776222002721","DOI":"10.1016\/j.lanepe.2022.100576"},{"key":"9426_CR21","doi-asserted-by":"crossref","unstructured":"Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurology [Internet]. Sep [cited 2026 Jul 15];5(9):735\u201341. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16914401\/","DOI":"10.1016\/S1474-4422(06)70537-3"},{"key":"9426_CR22","doi-asserted-by":"crossref","unstructured":"Barnes DE, Beiser AS, Lee A, Langa KM, Koyama A, Preis SR et al (2014) Development and validation of a brief dementia screening indicator for primary care. Alzheimers Dement [Internet]. Nov 1 [cited 2026 Jul 15];10(6):656. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4119094\/","DOI":"10.1016\/j.jalz.2013.11.006"},{"key":"9426_CR23","doi-asserted-by":"publisher","unstructured":"Schiepers OJG, K\u00f6hler S, Deckers K, Irving K, O\u2019Donnell CA, van den Akker M et al (2018) Lifestyle for brain health (LIBRA): a new model for dementia prevention. Int J Geriatr Psychiatry [Internet]. [cited 2026 Jul 15];33(1):167\u201375. Available from: https:\/\/doi.org\/10.1002\/gps.4700","DOI":"10.1002\/gps.4700"},{"key":"9426_CR24","doi-asserted-by":"crossref","unstructured":"Brookmeyer R, Abdalla N (2018) Estimation of lifetime risks of Alzheimer\u2019s disease dementia using biomarkers for preclinical disease. Alzheimers Dement [Internet]. [cited 2026 Mar 16];14(8):981\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29802030\/","DOI":"10.1016\/j.jalz.2018.03.005"},{"key":"9426_CR25","unstructured":"World Health Organization (WHO) (2021) WHO global air quality guidelines. Particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide. pp. 1\u2013360"},{"key":"9426_CR26","unstructured":"ARPA Lombardia | Qualit\u00e0 dell \u2019aria | I dati comunali - ARPA Lombardia [Internet]. [cited 2026 Jul 14]. Available from: https:\/\/www.arpalombardia.it\/temi-ambientali\/aria\/modellistica\/i-dati-comunali\/"},{"key":"9426_CR27","doi-asserted-by":"crossref","unstructured":"McWhirter L, Ritchie C, Stone J, Carson A (2020) Functional cognitive disorders: a systematic review. Lancet Psychiatry [Internet]. Feb 1 [cited 2026 Jan 4];7(2):191\u2013207. Available from: https:\/\/www.thelancet.com\/action\/showFullText?pii=S2215036619304055","DOI":"10.1016\/S2215-0366(19)30405-5"},{"key":"9426_CR28","doi-asserted-by":"publisher","first-page":"1665510","DOI":"10.3389\/fnagi.2025.1665510","volume":"17","author":"I Mavroudis","year":"2025","unstructured":"Mavroudis I, Petridis F, Franekova K, Visternicu M, Rarinca V, Burlui V et al (2025) Functional Cognitive Disorder: diagnostic challenges, clinical features, and future directions in a misunderstood condition. Front Aging Neurosci 17:1665510","journal-title":"Front Aging Neurosci"},{"key":"9426_CR29","doi-asserted-by":"crossref","unstructured":"Pennington C, Ball H, Swirski M (2019) Functional cognitive disorder: diagnostic challenges and future directions. Diagnostics [Internet]. [cited 2026 Jan 4];9(4):131. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6963804\/","DOI":"10.3390\/diagnostics9040131"},{"key":"9426_CR30","doi-asserted-by":"crossref","unstructured":"Mengel D, Soter E, Ott JM, Wacker M, Leyva A, Peters O et al (2025) Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer\u00b4s disease. Molecular Psych [Internet]. [cited 2026 Jan 4];30(7):3150\u20139. Available from: https:\/\/www.nature.com\/articles\/s41380-025-03021-0","DOI":"10.1038\/s41380-025-03021-0"},{"key":"9426_CR31","doi-asserted-by":"crossref","unstructured":"Gagliardi G, Houot M, Cacciamani F, Habert MO, Dubois B, Epelbaum S et al (2020) The meta-memory ratio: a new cohort-independent way to measure cognitive awareness in asymptomatic individuals at risk for Alzheimer\u2019s disease. Alzheimers Res Ther [Internet]. [cited 2026 Mar 19];12(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32408882\/","DOI":"10.1186\/s13195-020-00626-1"},{"key":"9426_CR32","doi-asserted-by":"publisher","first-page":"1394460","DOI":"10.3389\/fnagi.2024.1394460","volume":"16","author":"D L\u00f3pez-Martos","year":"2024","unstructured":"L\u00f3pez-Martos D, Su\u00e1rez-Calvet M, Mil\u00e0-Alom\u00e0 M, Gispert JD, Minguillon C, Quijano-Rubio C et al (2024) Awareness of episodic memory and meta-cognitive profiles: associations with cerebrospinal fluid biomarkers at the preclinical stage of the Alzheimer\u2019s continuum. Front Aging Neurosci 16:1394460","journal-title":"Front Aging Neurosci"},{"key":"9426_CR33","doi-asserted-by":"crossref","unstructured":"Trieu C, Van Harten AC, Van Leeuwenstijn MSSA, Schl\u00fcter LM, Boonkamp L, Aladdin A et al (2025) Longitudinal blood-based biomarkers and clinical progression in subjective cognitive decline. JAMA Netw Open [Internet]. [cited 2026 Jul 15];8(12):e2545862. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12676364\/","DOI":"10.1001\/jamanetworkopen.2025.45862"},{"key":"9426_CR34","doi-asserted-by":"crossref","unstructured":"Visser LNC, Minguillon C, S\u00e1nchez-Benavides G, Abramowicz M, Altomare D, Fauria K et al (2021) Dementia risk communication. A user manual for Brain Health Services\u2014part 3 of 6. Alzheimers Res Ther [Internet]. [cited 2026 Jan 4];13(1):170. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8507171\/","DOI":"10.1186\/s13195-021-00840-5"},{"key":"9426_CR35","doi-asserted-by":"crossref","unstructured":"Caprioglio C, Ribaldi F, Visser LNC, Minguillon C, Collij LE, Grau-Rivera O et al (2023) Analysis of psychological symptoms following disclosure of amyloid\u2013positron emission tomography imaging results to adults with subjective cognitive decline. JAMA Netw Open [Internet]. [cited 2026 Jan 4];6(1):e2250921\u2013e2250921. Available from: https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2800401","DOI":"10.1001\/jamanetworkopen.2022.50921"},{"key":"9426_CR36","doi-asserted-by":"crossref","unstructured":"van der Schaar J, Visser LNC, Ket JCF, Groot C, Pijnenburg YAL, Scheltens P et al (2023) Impact of sharing Alzheimer\u2019s disease biomarkers with individuals without dementia: a systematic review and meta-analysis of empirical data. Alzheimers Dement [Internet]. [cited 2026 Jul 15];19(12):5773\u201394. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37496313\/","DOI":"10.1002\/alz.13410"},{"issue":"10","key":"9426_CR37","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1002\/alz.12620","volume":"18","author":"FB Ketchum","year":"2022","unstructured":"Ketchum FB, Chin NA, Grill J, Gleason CE, Erickson C, Clark LR et al (2022) Moving beyond disclosure: Stages of care in preclinical Alzheimer\u2019s disease biomarker testing. Alzheimer\u2019s Dement 18(10):1969\u20131979","journal-title":"Alzheimer\u2019s Dement"},{"key":"9426_CR38","doi-asserted-by":"crossref","unstructured":"Mayan I, Roth H, Ghosh D, Whitson HE, Johnson KG (2025) Genetic and biomarker disclosure process in a memory and aging study. J Alzheimers Dis [Internet]. [cited 2026 Jul 15];104(2):312\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39924880\/","DOI":"10.1177\/13872877251315957"},{"key":"9426_CR39","doi-asserted-by":"crossref","unstructured":"Grill JD, Raman R, Ernstrom K, Wang S, Donohue MC, Aisen PS et al (2024) Immediate reactions to alzheimer biomarker disclosure in cognitively unimpaired individuals in a global truncated randomized trial. Neurol Clin Pract [Internet]. [cited 2026 Jul 15];14(2). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38585443\/","DOI":"10.1212\/CPJ.0000000000200265"},{"key":"9426_CR40","doi-asserted-by":"crossref","unstructured":"Erickson CM, Chin NA, Rosario HL, Peterson A, Johnson SC, Clark LR (2023) Feasibility of virtual Alzheimer\u2019s biomarker disclosure: Findings from an observational cohort. Alzheimers Dement (N Y) [Internet]. [cited 2026 Jul 15];9(3). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37521522\/","DOI":"10.1002\/trc2.12413"},{"issue":"2","key":"9426_CR41","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3233\/JAD-170813","volume":"62","author":"R Milne","year":"2018","unstructured":"Milne R, Bunnik E, Diaz A, Richard E, Badger S, Gove D et al (2018) Perspectives on Communicating Biomarker-Based Assessments of Alzheimer\u2019s Disease to Cognitively Healthy Individuals. J Alzheimer\u2019s Disease 62(2):487\u2013498","journal-title":"J Alzheimer\u2019s Disease"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09426-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09426-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09426-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:02:21Z","timestamp":1793671341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09426-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["9426"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09426-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was ethically approved by Comitato Etico Territoriale Lombardia 3, and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":1,"name":"Ethics","label":"Ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"824"}}